Laporan Laba Rugi (TTM)
Laporan Laba Rugi Hantech Bio-Technology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 12-31 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 267 | 240 | 235 | 229 | 266 | 328 | 440 | 521 | 725 | 775 | 796 | 748 | 743 | 721 |
| Change (%) | -9.90 | -2.35 | -2.41 | 16.05 | 23.26 | 34.24 | 18.47 | 39.15 | 6.88 | 2.71 | -5.95 | -0.70 | -3.04 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 140 | 139 | 141 | 142 | 159 | 190 | 249 | 289 | 404 | 438 | 460 | 443 | 444 | 438 |
| Change (%) | -0.78 | 0.89 | 0.88 | 12.04 | 19.69 | 30.83 | 16.14 | 40.02 | 8.40 | 4.87 | -3.72 | 0.28 | -1.41 | |
| % of Revenue | 52.63 | 57.96 | 59.88 | 61.90 | 59.76 | 58.03 | 56.55 | 55.44 | 55.79 | 56.58 | 57.78 | 59.15 | 59.73 | 60.73 |
| Gross Operating Profit | 126 | 101 | 94 | 87 | 107 | 137 | 191 | 232 | 320 | 336 | 336 | 306 | 299 | 283 |
| Change (%) | -20.03 | -6.82 | -7.31 | 22.56 | 28.57 | 38.96 | 21.50 | 38.06 | 4.96 | -0.11 | -9.01 | -2.11 | -5.46 | |
| % of Revenue | 47.37 | 42.04 | 40.12 | 38.10 | 40.24 | 41.97 | 43.45 | 44.56 | 44.21 | 43.42 | 42.22 | 40.85 | 40.27 | 39.27 |
| SG&A | 48 | 54 | 54 | 54 | 58 | 68 | 76 | 83 | 93 | 99 | 99 | 98 | 95 | 92 |
| Change (%) | 12.72 | -0.81 | -0.81 | 7.59 | 17.81 | 11.51 | 9.85 | 11.64 | 7.03 | -0.06 | -1.22 | -3.57 | -3.04 | |
| % of Revenue | 18.12 | 22.66 | 23.02 | 23.40 | 21.69 | 20.73 | 17.22 | 15.97 | 12.81 | 12.83 | 12.49 | 13.11 | 12.73 | 12.73 |
| R&D | 5 | 7 | 7 | 8 | 8 | 7 | 7 | 7 | 8 | 8 | 10 | 10 | 11 | 12 |
| Change (%) | 28.53 | 7.48 | 6.96 | 0.99 | -13.85 | -5.36 | 4.20 | 19.26 | 3.49 | 14.65 | 5.27 | 6.90 | 6.25 | |
| % of Revenue | 2.01 | 2.87 | 3.16 | 3.46 | 3.01 | 2.11 | 1.48 | 1.31 | 1.12 | 1.08 | 1.21 | 1.35 | 1.46 | 1.60 |
| OpEx | 194 | 201 | 202 | 203 | 224 | 265 | 331 | 379 | 505 | 546 | 569 | 551 | 549 | 541 |
| Change (%) | 3.39 | 0.66 | 0.65 | 10.44 | 18.01 | 24.94 | 14.47 | 33.42 | 8.07 | 4.13 | -3.13 | -0.28 | -1.54 | |
| % of Revenue | 72.76 | 83.49 | 86.06 | 88.76 | 84.46 | 80.86 | 75.26 | 72.72 | 69.72 | 70.50 | 71.47 | 73.62 | 73.92 | 75.06 |
| Operating Income | 73 | 40 | 33 | 26 | 41 | 63 | 109 | 142 | 220 | 229 | 227 | 197 | 194 | 180 |
| Change (%) | -45.39 | -17.55 | -21.29 | 60.37 | 51.81 | 73.58 | 30.64 | 54.43 | 4.13 | -0.67 | -13.02 | -1.85 | -7.29 | |
| % of Revenue | 27.24 | 16.51 | 13.94 | 11.24 | 15.54 | 19.14 | 24.74 | 27.28 | 30.28 | 29.50 | 28.53 | 26.38 | 26.08 | 24.94 |
| Interest Expense | -1 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | -3 | -5 | -6 | -5 | -5 | -4 |
| Change (%) | 52.31 | 5.04 | 4.79 | -7.01 | -8.45 | -15.88 | 10.85 | 144.70 | 40.13 | 22.69 | -5.58 | -14.97 | -17.30 | |
| % of Revenue | -0.38 | -0.64 | -0.69 | -0.74 | -0.60 | -0.44 | -0.28 | -0.26 | -0.46 | -0.60 | -0.72 | -0.72 | -0.62 | -0.52 |
| Net Income | 56 | 33 | 27 | 22 | 35 | 52 | 88 | 115 | 174 | 179 | 177 | 156 | 152 | 145 |
| Change (%) | -41.62 | -16.32 | -19.50 | 58.22 | 48.73 | 70.88 | 29.89 | 52.29 | 2.58 | -1.09 | -12.05 | -2.23 | -5.01 | |
| % of Revenue | 20.91 | 13.55 | 11.61 | 9.58 | 13.06 | 15.76 | 20.06 | 21.99 | 24.07 | 23.10 | 22.24 | 20.80 | 20.48 | 20.06 |
Source: Capital IQ
